-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Abacavir Sulfate + Lamivudine + Lopinavir + Ritonavir) in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Abacavir Sulfate + Lamivudine + Lopinavir + Ritonavir) in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Belimumab in Systemic Sclerosis (Scleroderma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Systemic Sclerosis (Scleroderma) Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal antibody...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal antibody specific for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etanercept Biosimilar in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Etanercept Biosimilar in Rheumatoid ArthritisDrug Details:Etanercept (Rymti, Etera, Nepexto) is a dimeric fusion protein consisting of...
-
Product Insights
New![]()
Net Present Value Model: Pfizer Inc’s Sisunatovir Hydrochloride
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Pfizer Inc's Sisunatovir Hydrochloride Drug Details: Sisunatovir is under development for the treatment of respiratory syncytial virus (RSV) infections in infants, toddlers and young children,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Belimumab in Idiopathic Inflammatory Myopathy (IIM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Idiopathic Inflammatory Myopathy (IIM) Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Belimumab in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Belimumab in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drug Details:Belimumab (Benlysta) is a human IgG1 monoclonal...
-
![]()
Victoria Gov – Geelong Children Emergency Department – Victoria
Equip yourself with the essential tools needed to make informed and profitable decisions with our Victoria Gov – Geelong Children Emergency Department – Victoria report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:Dive deep...
-
Product Insights
New![]()
Net Present Value Model: RegenxBio Inc’s RGX-111
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. RegenxBio Inc's RGX-111 Drug Details: RGX-111 is under development for the treatment of children and adult subjects with Mucopolysaccharidosis Type I (MPS I)....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Moxidectin in Elephantiasis (Lymphatic Filariasis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Moxidectin in Elephantiasis (Lymphatic Filariasis) Drug Details: Moxidectin is a semisynthetic derivative of nemadectin and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.